We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Inverness Medical Acquires Viva Diagnostika

By HospiMedica staff writers
Posted on 22 Jun 2004
In a move that will provide the company with a new European distribution network, Inverness Medical Innovations, Inc. More...
(Waltham, MA, USA), has acquired Viva Diagnostika (Cologne, Germany).

Viva Diagnostika is a distributor of professional diagnostic products in Germany and has established a distribution network for its existing diagnostic products, including the product lines acquired from Abbott Laboratories (Abbot Park, IL, USA) in 2003, as well as it own range of cardiac products in development.

Inverness Medical Innovations is a developer of advanced diagnostic devices with a focus on women's health, cardiology, and infectious disease. The company is a leading supplier of pregnancy and fertility/ovulation tests and rapid point-of-care diagnostics. The acquisition will give the company an established distribution network for its products in Germany, which is expected to be the largest market in Europe for various cardiac markers for which Inverness plans to introduce diagnostic products.




Related Links:
Inverness
Viva Diagnostika

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Pipette Calibration System
Artel PCS®
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.